+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Photobiomodulation Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242082
UP TO OFF until Jan 01st 2027
The Photobiomodulation Market is estimated at US$252.6 million in 2026 and is projected to grow at a CAGR of 10.5% to reach US$561.5 million by 2034.

Market Overview

The Photobiomodulation Market covers light based therapeutic solutions that use specific wavelengths to influence cellular activity, tissue recovery, pain management, and wellness applications. Its value chain includes light source suppliers, device designers, component makers, clinical distributors, therapy providers, and specialty care channels.

Core applications include pain relief, tissue healing, sports recovery, oral care, dermatology support, and wellness center treatments. At the same time, suppliers must respond to variable clinical protocols, reimbursement uncertainty, uneven practitioner training, and skepticism around claim quality.

Key Companies Analysed

  • THOR Photomedicine
  • BIOLITEC AG
  • Erchonia Corporation
  • Multi Radiance Medical
  • Vielight
  • Lumix2
  • Celluma
  • B-Cure Laser
  • Omega Laser Systems
  • K-Laser
  • LiteCure
  • Summus Medical Laser
  • ASA Laser
  • Medical Indicators
  • DJO Global
  • Zimmer MedizinSysteme
  • BioFlex Laser Therapy
  • Apollo Health
  • Novothor
  • LED Technologies

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Photobiomodulation Market Overview
2.1. Photobiomodulation Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Photobiomodulation Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Photobiomodulation Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Photobiomodulation Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
6. North America Photobiomodulation Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Photobiomodulation Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Photobiomodulation Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Photobiomodulation Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Photobiomodulation Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Photobiomodulation Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. THOR Photomedicine
11.2.2. BIOLITEC AG
11.2.3. Erchonia Corporation
11.2.4. Multi Radiance Medical
11.2.5. Vielight
11.2.6. Lumix2
11.2.7. Celluma
11.2.8. B-Cure Laser
11.2.9. Omega Laser Systems
11.2.10. K-Laser
11.2.11. LiteCure
11.2.12. Summus Medical Laser
11.2.13. ASA Laser
11.2.14. Medical Indicators
11.2.15. DJO Global
11.2.16. Zimmer MedizinSysteme
11.2.17. BioFlex Laser Therapy
11.2.18. Apollo Health
11.2.19. Novothor
11.2.20. LED Technologies
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • THOR Photomedicine
  • BIOLITEC AG
  • Erchonia Corporation
  • Multi Radiance Medical
  • Vielight
  • Lumix2
  • Celluma
  • B-Cure Laser
  • Omega Laser Systems
  • K-Laser
  • LiteCure
  • Summus Medical Laser
  • ASA Laser
  • Medical Indicators
  • DJO Global
  • Zimmer MedizinSysteme
  • BioFlex Laser Therapy
  • Apollo Health
  • Novothor
  • LED Technologies

Table Information